» Authors » D J Burt

D J Burt

Explore the profile of D J Burt including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 153
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Castro F, McGinn O, Krishnan S, Marinov G, Li J, Rutkowski A, et al.
Leukemia . 2012 Jan; 26(7):1487-98. PMID: 22266911
Although the overall prognosis in childhood acute lymphoblastic leukemia (ALL) is good, outcome after relapse is poor. Recurrence is frequently characterized by the occurrence of disease at extramedullary sites, such...
2.
Elkord E, Burt D
Scand J Immunol . 2011 Jun; 74(4):419-22. PMID: 21645031
We here describe the development of a novel ELISPOT assay for the detection and enumeration of IFNγ-secreting functional chimeric antigen receptor (CAR)-redirected T cells against carcinoembryonic antigen (CEA). This method...
3.
Giunti S, Tesch G, Pinach S, Burt D, Cooper M, Cavallo-Perin P, et al.
Diabetologia . 2007 Oct; 51(1):198-207. PMID: 17968528
Aims/hypothesis: Diabetic nephropathy is characterised by mesangial extracellular matrix accumulation. Monocyte chemoattractant protein-1 (MCP-1), a chemokine promoting monocyte infiltration, is upregulated in the diabetic glomerulus. We performed in vitro and...
4.
Davidson E, FAULKNER R, Sehr P, Pawlita M, Smyth L, Burt D, et al.
Vaccine . 2004 Jul; 22(21-22):2722-9. PMID: 15246603
Heterologous prime-boost vaccination schedules employing TA-HPV, a vaccinia virus encoding HPV 16/18 E6 and E7, in combination with TA-CIN, an HPV 16 L2E6E7 fusion protein, may offer advantages over the...
5.
Burt D, Gruden G, Thomas S, Tutt P, DellAnna C, Viberti G, et al.
Diabetologia . 2003 Apr; 46(4):531-7. PMID: 12679868
Aims/hypothesis: The hexosamine pathway has been implicated in the induction of TGFbeta1 expression and in the pathophysiology of diabetic glomerulopathy. Glucose-induced TGFbeta1 expression is mediated by p38 mitogen-activated-protein-kinase (p38-MAPK) and...
6.
Davidson E, Brown M, Burt D, Parish J, Gaston K, Kitchener H, et al.
Int J Cancer . 2001 Dec; 94(6):807-12. PMID: 11745482
Persistent infection with human papillomavirus (HPV) type 16 has been implicated in the etiology of cervical cancer. The E2 protein is required early in viral infection and therefore may serve...
7.
Brady C, Bartholomew J, Burt D, Glenville S, Telford N, Little A, et al.
Tissue Antigens . 2000 Jul; 55(5):401-11. PMID: 10885560
The consistent dysregulation of HLA expression in cervical neoplasia is likely to influence the natural history of the disease and prospects for cell-mediated vaccine therapies. We have studied the underlying...
8.
Bartholomew J, Glenville S, Sarkar S, Burt D, Stanley M, Ruiz-Cabello F, et al.
Cancer Res . 1997 Mar; 57(5):937-42. PMID: 9041198
A crucial event in the malignant progression of cervical intraepithelial neoplasia appears to be the up-regulation of high-risk human papillomavirus (HPV) early gene expression. Steroid hormones have been linked to...
9.
Bartholomew J, Stacey S, Coles B, Burt D, Arrand J, Stern P
Eur J Immunol . 1994 Dec; 24(12):3175-9. PMID: 7805746
Human papillomavirus (HPV) DNA encoding the oncogenic proteins E6 and E7 is usually retained in cervical carcinomas, implicating these proteins as potential target antigens for immune recognition in this virally...